Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianma Toutong Pian is a traditional Chinese medicine (TCM) product developed and manufactured by Liaoning Jindan Pharmaceutical. It is an approved and marketed formulation in China, primarily indicated for the relief of various types of headaches, including migraines, tension headaches, and those associated with wind-cold or liver-yang disturbances. The formula is composed of several herbal extracts, with *Gastrodia elata* (Tianma) serving as the principal ingredient due to its recognized sedative and analgesic properties. Other key components include *Angelica dahurica*, *Ligusticum chuanxiong*, and *Schizonepeta tenuifolia*, which work in combination to dispel wind, improve blood circulation, and alleviate pain. The therapeutic effects are attributed to the synergistic action of multiple bioactive compounds, such as gastrodin and ligustrazine, which modulate neurotransmitter systems and vascular tone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tianma toutong pian.